Abstract
Background In Japan, as a countermeasure against the COVID-19 outbreak, voluntary restrictions against going out (VRG) were applied.
Object We examined some associations among trip data provided by Apple Inc. and estimated an effective reproduction number R(t) at the city level.
Method We regressed R(t) on a polynomial function of daily data from Apple Inc. using the whole period and the sub-period after March 10, until the end of April. We predicted R(t) prospectively using the estimation results obtained in May.
Results Estimation results indicate R(t) as 5.22 in Tokyo and 1.62 in Osaka if VRG ceases and mobility reverts to a normal level. The critical level of R(t) <1 was found to be 70.0% in Tokyo and 91.2% in Osaka compared with the normal level.
Discussion and Conclusion Results demonstrate that mobility data from Apple Inc. are useful for prediction of R(t). Moreover, a 9–30% point reduction in trips from home was sufficient to maintain R(t)<1.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All information used for this study has been published. There is therefore no ethical issue related to this study.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
1
Blogs/Media
Author Videos